新里程健康科技集团股份有限公司 第六届董事会第三十七次会议决议公告

Group 1 - The company held its 37th meeting of the sixth board of directors on November 10, 2025, where all resolutions were deemed legal and effective [1][2]. - The board approved the proposal to change the registered capital, abolish the supervisory board, and amend the Articles of Association [3][20]. - The company will cancel the supervisory board, transferring its powers to the audit committee of the board [3][50]. Group 2 - The company will repurchase and cancel a total of 21,007,000 shares, reducing the total share capital from 3,408,388,753 shares to 3,387,381,753 shares [4][22]. - The company also approved the repurchase and cancellation of 2,370,000 restricted shares due to the departure of seven incentive targets, reducing the total share capital from 3,410,758,753 shares to 3,408,388,753 shares [4][48]. Group 3 - The board approved the revision of the "Rules of Procedure for Shareholders' Meetings," renaming it to "Rules of Procedure for Shareholders' Meetings" [7][9]. - The board also approved the revision of the "Rules of Procedure for Board Meetings" [10][11]. - A series of internal governance documents were revised and approved, including the "President's Work Guidelines" and "Independent Director Work System" [11][12]. Group 4 - The company plans to hold its first extraordinary general meeting of shareholders on November 28, 2025, to discuss the approved proposals [16][28]. - The meeting will be conducted both in-person and via online voting, with specific time slots for each voting method [30][40].